Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-13T00:37:52.513Z Has data issue: false hasContentIssue false
  • English
  • Français

Carbapenem-Resistant Enterobacteriaceae: A Statewide Survey of Detection in Massachusetts Hospitals

Published online by Cambridge University Press:  02 January 2015

Evangeline Thibodeau ,
Robert Duncan ,
David R. Snydman ,
Barbara Bolstorff ,
Johanna Vostok ,
Kerri Barton  and
Alfred DeMaria Jr.
Evangeline Thibodeau*
Affiliation:
Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts
Robert Duncan
Affiliation:
Lahey Clinic and Tufts University School of Medicine, Burlington, Massachusetts
David R. Snydman
Affiliation:
Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts
Barbara Bolstorff
Affiliation:
Massachusetts Department of Public Health, Jamaica Plain, Massachusetts
Johanna Vostok
Affiliation:
Massachusetts Department of Public Health, Jamaica Plain, Massachusetts
Kerri Barton
Affiliation:
Massachusetts Department of Public Health, Jamaica Plain, Massachusetts
Alfred DeMaria Jr.
Affiliation:
Massachusetts Department of Public Health, Jamaica Plain, Massachusetts
*
Tufts Medical Center Box #238, 800 Washington Street, Boston, MA 02111 (evangeline.thibodeau@gmail.com)
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Research Briefs
Information
Infection Control & Hospital Epidemiology , Volume 33 , Issue 9 , September 2012 , pp. 954 - 956
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2012 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Nordmann, P, Cuzon, G, Naas, T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009;9:228–236.10.1016/S1473-3099(09)70054-4Google Scholar
2. Patel, G, Huprikar, S, Factor, SH, Jenkins, SG, Calfee, DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29:1099–1106.Google Scholar
3. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: twenty-first informational supplement. CLSI document M-100-S21. Wayne, PA: CLSI, 2011.Google Scholar
4. Gupta, N, Limbago, BM, Patel, JB, Kallen, AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011;53:60–67.10.1093/cid/cir202Google Scholar
5. Hidron, AI, Edwards, JR, Patel, J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008;29(11):996–1011.10.1086/591861Google Scholar
6. Srinivasan, A, Patel, JB. Klebsiella pneumoniae carbapenemase-producing organisms: an ounce of prevention really is worth a pound of cure. Infect Control Hosp Epidemiol 2008;29:1107–1109.10.1086/594129Google Scholar
7. Yigit, H, Queenan, AM, Anderson, GJ, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae . Antimicrob Agents Chemother 2001;45:1151–1161.10.1128/AAC.45.4.1151-1161.2001Google Scholar